Coinbase Global3 min read
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S.
By Duncan RileySiliconANGLE

Read the full story
Originally published by SiliconANGLE on Oct 22, 2026.
Comments
Sign in to join the discussion.